AU2023345654A1 - Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy - Google Patents
Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy Download PDFInfo
- Publication number
- AU2023345654A1 AU2023345654A1 AU2023345654A AU2023345654A AU2023345654A1 AU 2023345654 A1 AU2023345654 A1 AU 2023345654A1 AU 2023345654 A AU2023345654 A AU 2023345654A AU 2023345654 A AU2023345654 A AU 2023345654A AU 2023345654 A1 AU2023345654 A1 AU 2023345654A1
- Authority
- AU
- Australia
- Prior art keywords
- dota
- glu
- sifa
- cck
- moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22196630 | 2022-09-20 | ||
| EP22196630.2 | 2022-09-20 | ||
| PCT/EP2023/063469 WO2024061483A1 (en) | 2022-09-20 | 2023-05-19 | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023345654A1 true AU2023345654A1 (en) | 2025-02-27 |
Family
ID=83994946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023345654A Pending AU2023345654A1 (en) | 2022-09-20 | 2023-05-19 | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP4590347A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025532619A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250073200A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119907695A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023345654A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3264385A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL319379A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025003151A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024061483A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12642876B1 (en) | 2025-10-30 | 2026-06-02 | Perspective Therapeutics, Inc. | Cholecystokinin-2 receptor targeted compounds and use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3412303A1 (en) * | 2017-06-08 | 2018-12-12 | Medizinische Universität Innsbruck | Improved pharmacokinetics and cholecystokinin-2 receptor (cck2r) targeting for diagnosis and therapy |
| KR20240027896A (ko) * | 2017-07-28 | 2024-03-04 | 테크니쉐 우니베르지테트 뮌헨 | 이중 모드 방사성 트레이서 및 치료법 |
| EP4023250A1 (en) * | 2021-01-04 | 2022-07-06 | Technische Universität München | Dual mode radiotracer and -therapeutics |
-
2023
- 2023-05-19 CA CA3264385A patent/CA3264385A1/en active Pending
- 2023-05-19 IL IL319379A patent/IL319379A/en unknown
- 2023-05-19 EP EP23727562.3A patent/EP4590347A1/en active Pending
- 2023-05-19 WO PCT/EP2023/063469 patent/WO2024061483A1/en not_active Ceased
- 2023-05-19 JP JP2025515980A patent/JP2025532619A/ja active Pending
- 2023-05-19 AU AU2023345654A patent/AU2023345654A1/en active Pending
- 2023-05-19 KR KR1020257012384A patent/KR20250073200A/ko active Pending
- 2023-05-19 EP EP25193071.5A patent/EP4631959A3/en active Pending
- 2023-05-19 CN CN202380067423.2A patent/CN119907695A/zh active Pending
-
2025
- 2025-03-18 MX MX2025003151A patent/MX2025003151A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20250073200A (ko) | 2025-05-27 |
| CA3264385A1 (en) | 2024-03-28 |
| CN119907695A (zh) | 2025-04-29 |
| JP2025532619A (ja) | 2025-10-01 |
| WO2024061483A1 (en) | 2024-03-28 |
| MX2025003151A (es) | 2025-04-02 |
| EP4590347A1 (en) | 2025-07-30 |
| IL319379A (en) | 2025-05-01 |
| EP4631959A3 (en) | 2025-12-17 |
| EP4631959A2 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018308699B2 (en) | Dual mode radiotracer and -therapeutics | |
| AU2019469641B2 (en) | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders | |
| KR20130132935A (ko) | Nota에 의해 복합체를 형성한 알루미늄―〔18〕플루오라이드로 표지된 her2 결합 펩티드 | |
| KR20130132939A (ko) | 18f - 함유 유기실리콘 화합물로 표지된 her2 결합 펩티드 | |
| JP7838149B2 (ja) | 癌のイメージングおよび治療のための修飾されたgrprアンタゴニストペプチド | |
| JP2003517037A (ja) | 新規ソマトスタチン類似体 | |
| EP4631959A2 (en) | Novel minigastrin-derived cholecystokinin 2 receptor binding molecules for imaging and targeted radiotherapy | |
| JP6410339B2 (ja) | 放射性核種標識オクトレオチド誘導体 | |
| US20250313579A1 (en) | Ligand compounds comprising a chelating group as a bridging group | |
| CN117320759A (zh) | 放射性药物生长抑素受体配体及其前体 | |
| WO2025162868A1 (en) | Compounds comprising a silicon-based fluoride acceptor group useful as radiopharmceutical compounds | |
| JP2025525111A (ja) | 放射性医薬品のためのケイ素系フッ化物アクセプター基 | |
| WO2025171887A1 (en) | Radiolabeled complexes and pharmaceutical compositions including the same | |
| CN120239618A (zh) | 放射性标记的psma配体化合物及其前体 |